Kohei Nakachi

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

Takuji Okusaka, Kohei Nakachi, Akira Fukutomi et al. · British Journal of Cancer · 2010 · 752 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

Masatoshi Kudo, Kazuho Imanaka, Nobuyuki Chida et al. · European Journal of Cancer · 2011 · 573 citations

Medicine, Oncology, Pharmacokinetics +15

Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Yu Sawada, Toshiaki Yoshikawa, Daisuke Nobuoka et al. · Clinical Cancer Research · 2012 · 299 citations

Medicine, Immunology, Oncology +17

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

Kohei Nakachi, Masafumi Ikeda, Masaru Konishi et al. · The Lancet · 2023 · 232 citations

Medicine, Oncology, Surgery +11

Phase I study of sorafenib in Japanese patients with hepatocellular carcinoma

Junji Furuse, Hiroshi Ishii, Kohei Nakachi et al. · Cancer Science · 2007 · 194 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17